This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than ...
stockhead14 小时
Market Highlights: All eyes on another ASX record, and why investors could pile on stocks ...
ASX could hit record high despite mixed bag on Wall Street. US stocks expected to outperform bonds as Fed cuts rates.
eNCA15 小时Opinion
New drug for schizophrenics has experts excited
WASHINGTON - Experts expressed enthusiasm after US health regulators approved the first new form of treatment for ...
Health and Me on MSN22 小时
Breakthrough in Schizophrenia Treatment: FDA Approves Cobenfy
New drug offers hope for patients with Schizophrenia that has long eluded effective treatment. Read on to know more.
ASX set for bright start to week, Wall Street mixed
US stocks closed another record-setting week with a muted performance, as hope built on Wall Street that the US economy can ...